March 15, 2018 A study by the Harvard Pilgrim Health Care Institute found that contrary to current hepatitis C treatment guidelines, an eight-week treatment regimen may be just as effective as 12 weeks in black patients. The new study of more than 2,600 patients in Kaiser Permanente’s Northern California region also showed that more people […]Continue Reading ...
March 1, 2018 Fear protects people from danger. A team from the Technical University of Munich (TUM) and Helmholtz Zentrum München has discovered that this applies even to pathological anxiety disorders. Patients who generally suffer from severe anxiety are likely to heed the symptoms of a heart attack earlier and seek medical treatment sooner, thus […]Continue Reading ...
March 1, 2018 Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it to one of the most frequent cancer-causing genes. That gene, KRAS, is mutated in approximately 20 percent of all human cancers and has a major presence in […]Continue Reading ...
Action Points The U.S. Preventative Service Task Force (USPSTF) recommends that obese people be referred to an intensive, behavioral multicomponent intervention, citing “adequate evidence” and “moderate certainty” (Level B) that this type of therapy can facilitate clinically significant amounts of weight loss. Note that despite positive trials of pharmacotherapy intervention, the report noted the findings […]Continue Reading ...
ATLANTA — Hepatitis A vaccination should be given following exposure in all persons ages 12 months and older, the Advisory Committee on Immunization Practices (ACIP) said. In a unanimous 14-0 vote, the ACIP voted that “hepatitis A vaccines should be administered as post-exposure prophylaxis,” for this population, and immune globulin should be administered to adults […]Continue Reading ...
Action Points There was no significant difference in weight change between a healthy low-fat diet versus a healthy low-carbohydrate diet in a 12-month study, and neither genotype pattern nor baseline insulin secretion was associated with dietary effects on weight loss. Note that the study population was unique in being very healthy, without significant comorbidity, and […]Continue Reading ...
Gilead’s Biktarvy Cleared for Use in HIV-1 Infection In February, the FDA approved Gilead’s Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide, or BIC/FTC/TAF), a combination, once-daily, oral treatment for HIV-1 infection in adults. Biktarvy is used for the treatment of two HIV groups: either those who have no antiretroviral treatment history or those who are virologically […]Continue Reading ...
NORTH CHICAGO, Ill., Feb. 16, 2018 /PRNewswire/ — AbbVie (NYSE: ABBV), a global research and development-based biopharmaceutical company, today announced new results from the double-blinded extension phase of the Phase 2 CELEST study, showing that many patients treated with upadacitinib who achieved clinical response after the 16-week induction phase maintained their response to treatment after […]Continue Reading ...
Credit: CC0 Public Domain A diet rich in saturated fat and sugar not only leads to obesity, it creates inflammation in the nucleus accumbens, a part of the brain that controls mood and the feeling of reward. And this inflammation can lead to depressive, anxious and compulsive behaviour and disrupt metabolism, according to a new […]Continue Reading ...
Sorrento Therapeutics Subsidiary, Scilex, Receives FDA Approval for Non-Opioid ZTlido (lidocaine topical system) 1.8% for Post-Herpetic Neuralgia Pain SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ:SRNE) (“Sorrento”), and its majority-owned subsidiary, Scilex Pharmaceuticals Inc. (“Scilex”), received approval from the U.S. Food and Drug Administration (FDA) for ZTlido (lidocaine topical system) 1.8%. […]Continue Reading ...
March 2, 2018 A metal plate might be the cure for a common foot injury seen in athletes and people on their feet all day, according to new research conducted at Houston Methodist. In a paper published online February 21 by The American Journal of Sports Medicine, researchers led by Kevin Varner, M.D., a Houston […]Continue Reading ...
March 2, 2018 New research has found no evidence Omega-3 fish oil supplements help aid or improve the reading ability or memory function of underperforming school-children. These findings are in contradiction to an earlier study run by the same team using the same supplement. In the second high-quality trial of its kind, published in PLOS-ONE, […]Continue Reading ...
Credit: Yale University Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it to one of the most frequent cancer-causing genes. That gene, KRAS, is mutated in approximately 20 percent of all human cancers and has a major presence in […]Continue Reading ...
February 27, 2018 Health authorities will need to focus on more than eating habits if they are going to combat the obesity epidemic. A study led by the University of Waterloo found it’s generally a combination of unhealthy behaviors among youth that could be the greatest predictors of whether or not young people will experience […]Continue Reading ...
Credit: University of Liverpool A new study, published in the Addiction journal, conducted by researchers from the University of Liverpool highlights the ineffectiveness of a specific drug treatment for alcohol use disorders. Baclofen is a medication which has been used since the 1970s as an anti-spasticity treatment. More recently it has been used as a […]Continue Reading ...
- Insurance Company Hurdles Burden Doctors, May Harm Patients
- Renal Transplant from HCV-Positive Donors Feasible
- Myelodysplastic syndrome: MedlinePlus Medical Encyclopedia
- Research reveals brain mechanism involved in language learning
- Many parents still hesitate to try early peanut introduction, survey finds
- Audiologist urges tinnitus sufferers facing ‘revolving door healthcare’ to seek support
- Study reveals impact of prostate cancer on wives and partners of sufferers
- ‘Almost a Miracle Drug’: What We Heard This Week
- Study shows NIH spent >$100 billion on basic science for new medicines
- Columbia researchers identify nerve cells that drive fruit fly’s escape behavior
- Sartorius Stedim Biotech selected by ABL Europe to supply single-use process technologies
- Increase in coffee consumption may help battle against colon cancer
- Hydrogel may accelerate healing of diabetic ulcers
- Dermira’s Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints
- DePuy Synthes introduces ACTIS Total Hip System for improving initial implant stability
- ‘Oh, It Was Nothing’
- Herbal drug kratom linked to salmonella illnesses, CDC says
- New optical point-of-care device could enhance screening for thyroid nodules
- FDA Expands Approval of Adcetris (brentuximab vedotin) for First-Line Treatment of Stage III or IV Classical Hodgkin Lymphoma in Combination with Chemotherapy
- Eosinophilic Esophagitis: Late Manifestation of Allergic March